Lupin in Partnership to Market Locoid Lotion in the US

by Kathy Jones on  September 24, 2013 at 6:57 PM Corporate News
RSS Email Print This Page Comment
Font : A-A+

Mumbai-based pharmaceutical company Lupin revealed that it has reached an agreement with US-based Onset Dermatologics through which it will be marketing the skin disease treatment medicine Locoid Lotion in the American market.
 Lupin in Partnership to Market Locoid Lotion in the US
Lupin in Partnership to Market Locoid Lotion in the US

The agreement was made between Onset Dermatologics and Lupin's American subsidiary, Lupin Pharmaceuticals which grants exclusive rights to Lupin for marketing Locoid Lotion, a corticosteroid used in topical treatment of mild to moderate Atopic Dermatitis in patients 3 months of age and older.

Stating that it will help expand the market for Locoid Lotion, Onset Dermatologics President Bob Moccia said, "This partnership will give pediatricians greater opportunity to utilize Locoid lotion in their patients while Onset maintains its focus on promoting Locoid to the dermatology community. We are confident that Locoid will continue to be the most prescribed mid-potency steroid brand in the U.S."

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive